Fracture prevention in patients with cognitive impairment presenting with a hip fracture: secondary analysis of data from the HORIZON Recurrent Fracture Trial. [electronic resource]
Producer: 20141001Description: 77-83 p. digitalISSN:- 1433-2965
- Aged
- Aged, 80 and over
- Bone Density Conservation Agents -- therapeutic use
- Cognition Disorders -- complications
- Diphosphonates -- therapeutic use
- Double-Blind Method
- Female
- Follow-Up Studies
- Hip Fractures -- epidemiology
- Humans
- Imidazoles -- therapeutic use
- Incidence
- Kaplan-Meier Estimate
- Male
- Middle Aged
- Osteoporosis -- complications
- Osteoporotic Fractures -- epidemiology
- Psychiatric Status Rating Scales
- Secondary Prevention
- Treatment Outcome
- Zoledronic Acid
No physical items for this record
Publication Type: Journal Article; Multicenter Study; Randomized Controlled Trial
There are no comments on this title.
Log in to your account to post a comment.